Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Grants Priority Review to Johnson & Johnson’s Nipocalimab for Generalized Myasthenia Gravis

admin January 12, 2025

Priority Review was based on results from the Phase III Vivacity-MG3 study of nipocalimab in patients with generalized myasthenia gravis.

LEAVE A RESPONSE Cancel reply

admin

Medicine

FDA Grants Fast Track Designation to Adicet Bio’s CAR T-cell Therapy for Systemic Lupus Erythematosus

admin February 5, 2025

Medicine

Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky

admin August 4, 2024

Medicine

Synchron, Potential Competitor to Elon Musk’s Neuralink, Obtains Equity Interest in Acquandas to Accelerate Development of Brain-Computer Interface

admin February 6, 2024

Medicine

FDA Approves Protega Pharmaceuticals’ Roxybond for Severe Pain Management

admin October 30, 2024